Sermo
Verified clinician network monetised through research, insights and healthcare advertising.
Available information varies by company and source.
Profile record updated:
Company facts
- Entity type
- COMPANY
- Founded
- 2000
- Headquarters
- 9 Crosby St, Floor 2, New York, NY 10013, US
- Company size
- 201–500
- Market role
- Publisher & Media Owner
- Official website
- sermo.com
What Sermo does
Sermo creates value by aggregating and retaining a credential-verified healthcare professional community, then packaging access to that audience in several commercial forms. On one side, clinicians join the platform for peer discussion, content, drug knowledge, and paid participation opportunities. On the other, life sciences and healthcare clients pay for market research, custom insight generation, ongoing sentiment measurement, and targeted media access. This makes Sermo a dual-sided platform whose core asset is trusted access to verified clinicians and the resulting first-party data and engagement environment.
Category differentiation
Sermo is not an electronic health record, telemedicine provider, or general consumer health forum. It is a verified clinician community and healthcare intelligence platform monetised through research, insights, and advertising.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Sermo is a healthcare-focused digital platform built around a verified community of clinicians, especially physicians. It operates a closed professional network where healthcare professionals discuss cases, share treatment experience, access peer-generated content, and participate in paid research. The company monetises this community primarily by selling access to its clinician audience and data to pharmaceutical, biotech, medical device, and healthcare organisations. Its revenue model combines market research services, insight products, analytics, and advertising. Sermo also runs a self-serve ad platform for healthcare marketers seeking targeted access to verified healthcare professionals inside a closed environment. In practice, Sermo functions as a hybrid of a professional social platform, a physician research panel, and a healthcare media and insights business.
Company news briefing
Briefing updated:
Sermo continues to expand its healthcare market intelligence, specifically regarding the commercial complexities and prescribing risks within the GLP-1 and weight management sectors. This strategic focus reinforces the organisation’s role in providing physician-led data to address market demand and virtual care challenges. Under the leadership of CEO Peter Kirk, CMO Erin Fitzgerald, and CFO Andy Bray, the company also maintains community engagement via its recurring Run for Research initiative, further solidifying its position as a central hub for professional medical dialogue and actionable industry insights.
Business model & monetisation
Sermo monetises primarily through B2B revenue streams. These include project-based market research fees for customised surveys and fieldwork, managed-service fees for physician insight and engagement programmes, and campaign-based advertising revenue from marketers using its self-serve and managed media products. The clinician side is generally free to use, with member incentives funded by research demand; this supports supply acquisition, engagement, and data quality. Commercially, the model blends service fees, media spend, and insight product revenue rather than consumer subscription income.
- Custom physician market research
- Project fees for survey design, fielding, sampling, and reporting
- Healthcare advertising and campaign activation
- Campaign-based spend and targeting fees via self-serve and managed media products
- Insight reports and analytics products
- Managed-service and report-based fees
- Ongoing sentiment and measurement products
- Subscription or recurring access to tracking outputs
Products & capabilities
No products with linked sources are available in this view.
Products & market categories
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
No sufficiently sourced and dated signals are available for this view.
Explore company relationships
Questions about Sermo
What is Sermo?
Sermo is a verified healthcare professional network that also sells market research, insight, and advertising access to healthcare and life sciences organisations.
Who uses Sermo?
Clinicians use it for peer discussion, drug knowledge, and paid research participation, while pharma, biotech, medical device, and healthcare organisations use it for research and targeted engagement.
How does Sermo make money?
It makes money mainly from enterprise clients through customised market research, insight products, and healthcare advertising and campaign services.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
19 publicly documented primary sources and citations linked across the market graph.
Continue your research on Sermo
Explorer includes additional company details, a Watchlist for up to 25 companies and your personal Strategic Intelligence Agent. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.
Free, with no time limit.